Journal article
Treatment-resistant OCD: Pharmacotherapies in adults
Abstract
Serotonin reuptake inhibitor (SRI) medications are well established as first-line pharmacotherapeutic treatment for Obsessive-Compulsive Disorder (OCD). However, despite the excellent safety profile and demonstrated efficacy of these medications, a substantial proportion of individuals with OCD fail to attain sufficient benefit from SRIs. In this narrative review, we discuss clinical features of OCD that have been associated with poorer …
Authors
van Roessel PJ; Grassi G; Aboujaoude EN; Menchón JM; Van Ameringen M; Rodríguez CI
Journal
Comprehensive Psychiatry, Vol. 120, ,
Publisher
Elsevier
Publication Date
1 2023
DOI
10.1016/j.comppsych.2022.152352
ISSN
0010-440X